Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

118265

Sigma-Aldrich

3-(p-Tolyl)propionic acid

98%

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Linear Formula:
CH3C6H4CH2CH2CO2H
CAS Number:
1505-50-6
Molecular Weight:
164.20
EC Number:
216-132-9
MDL number:
MFCD00016561
UNSPSC Code:
12352100
PubChem Substance ID:
24847365
NACRES:
NA.22

Assay

98%

form

solid

mp

115-118 °C (lit.)

functional group

carboxylic acid

SMILES string

Cc1ccc(CCC(O)=O)cc1

InChI

1S/C10H12O2/c1-8-2-4-9(5-3-8)6-7-10(11)12/h2-5H,6-7H2,1H3,(H,11,12)

InChI key

LDYGRLNSOKABMM-UHFFFAOYSA-N

Application

3-(p-Tolyl)propionic acid was used during the coupling of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide with 4,5-diphenyl-2-(2-p-tolyl-ethyl)-4,5-dihydro-1H-imidazole resin.

Pictograms

Exclamation mark
GHS07

Signal Word

Warning

Hazard Statements

H315,H319,H335

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

Target Organs

Respiratory system

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
MKBL6303V
04615BJ
09407BE
01926DD
09629TC

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Gregory H Merriman et al.
Bioorganic & medicinal chemistry letters, 15(2), 435-438 (2004-12-18)
A series of 4,5-diarylimidazoline libraries were prepared using high-throughput solid-phase and microwave techniques. The compounds were evaluated as P2X(7) antagonists and their SAR is described.
Christopher S Wilson et al.
Chemistry (Weinheim an der Bergstrasse, Germany), 26(50), 11593-11603 (2020-06-11)
Dinuclear metallodrugs offer much potential in the development of novel anticancer chemotherapeutics as a result of the distinct interactions possible with bio-macromolecular targets and the unique biological activity that can result. Herein, we describe the development of isostructural homo-dinuclear OsII

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service